Founded in Shanghai Zhangjiang Hi©✘gh-tech Park, Shanghai WD Pharm¥$aceutical Co., Ltd.(WDP"∞) is a biotech company with£★δ top priority to identify and address ε₽≈the unmet medical needs through d☆ ∏♥eveloping proprietary delivery syste↑©₩₹ms and formulations.→₩‍$

Some clinically proven activ​≤₽≤e pharmaceutical agents (APIs↓÷ε​) have their absorption window li☆•¥mited at the upper gastroint₹×£≠estinal tract. For these AP♥¶♦Is, the existing delivery techn‍£↓ologies have limitation toα ¶ prolong the therapeuticγφ€ coverage.

It’s also a challenge₩ε× to administer medicines to pediatric ±✘s and geriatrics who have difficulty  ★in swallowing large £≠¶size tablets and capsules, which will l₽←ead to issues of palatabili ♣ty and compliance.

Based on the challenges↓→< described above, WDP ®∑is developing two proprietarβ‌©y drug/device combination delivery pla×€×€tforms, (1) UGi-Pump®,>​↔€ the upper GI tract conε<≈trolled-release system, ¶<✔ (2) AcuSiS®, the pediatr™←ic and geriatric drug delivery system.♣♠×↕

WDP utilizes these twφ☆♠o delivery platforms to develop ric'£≤h product portfolio focusin↕☆↓¥g on Parkinson’s disease thera$π§"peutic area, coverin $€g from early stage to late stage, ☆'from day-time management t↓©o morning stiffness pr®∑×‍evention, and from re¥φ‌gular treatment to intermi♠∑ttent treatment of “OFF” e→↓pisodes.